Back to products
PeptidePower CJC 1295 (No DAC) — research vial
CJC 1295 (No DAC) Price range: $65.99 through $116.99

Slu-pp-332 Capsules

Price range: $70.80 through $114.00

Encapsulated powder - research reference material

This material is supplied solely as a laboratory research article. Buyer is responsible for ensuring lawful purchase, handling, storage, and use. We do not provide administration or therapeutic guidance.

SLU-PP-332 Capsules - Synthetic PPAR-Delta Agonist Compound, Research Reference Material

FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.

2D chemical structure of SLU-PP-332 Capsules - Synthetic PPAR-Delta Agonist Compound, Research Reference Material
Two-dimensional chemical structure. Depiction for identification only.

Analytical Identity

Identity & nomenclature
Common nameSLU-PP-332 Capsules
CAS Number303760-60-3
PubChem CID5338394
InChIKeyRNZIMBFHRXYRLL-XDHOZWIPSA-N
SMILESC1=CC=C2C=C(C=CC2=C1)C=NNC(=O)C3=CC=C(C=C3)O
Physicochemical
Molecular formulaC18H14N2O2
Molecular weight290.32 g/mol
Monoisotopic mass290.1055 Da
AppearanceEncapsulated powder
Physical formCapsules
Quality & provenance
PurityNot less than 98% by HPLC (see lot-specific Certificate of Analysis)
SourceSynthetic
Catalog / SKUSlu-pp-332-Caps

SLU-PP-332 Capsules is supplied strictly as a laboratory research reference material intended for in-vitro and laboratory bench-top investigations. Each unit contains encapsulated synthetic powder characterized by the molecular formula C18H14N2O2, a molecular weight of 290.32 g/mol, and a monoisotopic mass of 290.1055 Da, catalogued under CAS 303760-60-3 and PubChem CID 5338394. The compound is registered under InChIKey RNZIMBFHRXYRLL-XDHOZWIPSA-N with the canonical SMILES C1=CC=C2C=C(C=CC2=C1)C=NNC(=O)C3=CC=C(C=C3)O, corresponding to a 4-hydroxybenzohydrazide scaffold bearing a naphthalen-2-ylmethylidene substituent on the terminal nitrogen. This acylhydrazone architecture combines an aromatic naphthyl system, a conjugated C=N linkage, and a para-hydroxyphenyl carbonyl motif, giving SLU-PP-332 Capsules a defined chromophore and a molecular topology of interest to analytical chemists working with hydrazide-class reference standards.

The material is presented in capsule form as an encapsulated synthetic powder, packaged to support gravimetric handling, reconstitution studies in laboratory solvents, and comparative chromatographic workflows. Purity is specified at not less than 98% by HPLC, with identity and lot-to-lot consistency documented on a Certificate of Analysis released against each production batch. Analysts referencing SLU-PP-332 Capsules in method development typically leverage the aromatic naphthyl and phenolic hydroxyl functionalities for UV detection, while the discrete monoisotopic mass supports unambiguous confirmation by high-resolution mass spectrometry and orthogonal characterization by 1H/13C NMR and FT-IR against the tabulated structural descriptors.

Published scientific literature has examined SLU-PP-332 in preclinical laboratory research contexts, and this listing exists to support reproducibility, comparative structural analysis, and analytical benchmarking of the reference molecule. PEPTIDE.Power makes no therapeutic, diagnostic, or efficacy claims regarding this material and provides no administration, dosing, or handling guidance beyond standard laboratory practice for characterized organic reference compounds. SLU-PP-332 Capsules is not a drug, dietary supplement, cosmetic, or food, and is not intended for human or veterinary use, injection, or ingestion. Full identity, purity, and chromatographic data are consolidated on the lot-specific Certificate of Analysis, which is available on request to qualified research purchasers.

Physical format

Supplied as encapsulated research material in a sealed container. A research reference material - not a finished product. Net contents per unit are shown in the product options.

Certificate of Analysis

AnalyteSLU-PP-332 Capsules
CAS Number303760-60-3
AppearanceEncapsulated powder
IdentityConfirmed by HPLC and mass spectrometry

Lot-specific COA available — contact [email protected] with your lot number.

Storage & handling

Store the sealed container at room temperature, protected from light, heat, and moisture. Handle per standard laboratory practice; a Safety Data Sheet (SDS) is available on request.

Scientific references

The following are independent, peer-reviewed publications provided for reference. They describe third-party research and are not representations by POWER BIOTECH LLC regarding this product.

  1. A Synthetic ERR Agonist Alleviates Metabolic Syndrome — https://pmc.ncbi.nlm.nih.gov/articles/PMC10801787/
  2. A Synthetic ERR Agonist Alleviates Metabolic Syndrome — https://pubmed.ncbi.nlm.nih.gov/37739806/

Eligibility & terms of sale

This material is sold to qualified laboratory and research buyers for lawful research use only. It is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use this material only for lawful laboratory research.

FAQ

What is the purity and how is it verified?
Not less than 98% by HPLC; see the Certificate of Analysis for the lot-specific result.

What form does it ship in?
Encapsulated research material in a sealed container.

Can you advise on dosing, reconstitution, or administration?
No. We provide batch documentation, storage, and handling information only; we do not provide dosing, reconstitution, administration, or therapeutic guidance.

Is lot-specific documentation available?
Yes - contact [email protected] with your lot number for the Certificate of Analysis.

Related reference materials

Sold by POWER BIOTECH LLC, Casper, WY 82609, United States · [email protected]. FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.